These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24531033)

  • 1. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Mocchegiani F; Di Matteo F; Riva A; Lukasiak J; Scalise G; Saba V; Giacometti A
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
    Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
    J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac Sodium Restores the Sensitivity of Colistin-Resistant Gram-Negative Bacteria to Colistin.
    Fu Q; Liu S; Hu P; Chen H; Zheng J; Shi S; Xu M; Zhou T; Sun Y
    ACS Infect Dis; 2024 Aug; 10(8):2860-2869. PubMed ID: 39073350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis.
    Cirioni O; Simonetti O; Morroni G; Brescini L; Kamysz W; Kamysz E; Orlando F; Pierpaoli E; Caffarini M; Orciani M; Agostinelli C; Offidani A; Provinciali M; Giacometti A
    Curr Top Med Chem; 2018; 18(24):2127-2132. PubMed ID: 30569865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
    Matzneller P; Strommer S; Österreicher Z; Mitteregger D; Zeitlinger M
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1989-94. PubMed ID: 26178070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.